CNY 2.94
(1.03%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -509.76 Million CNY | 75.43% |
2022 | 338.39 Million CNY | -962.57% |
2021 | -297.01 Million CNY | 202.47% |
2020 | -399.45 Million CNY | -107.2% |
2019 | 407.6 Million CNY | -33.26% |
2018 | -1.35 Billion CNY | 274.49% |
2017 | 229.29 Million CNY | -43.15% |
2016 | 672.23 Million CNY | 16.92% |
2015 | 561.55 Million CNY | 316.09% |
2014 | 138.18 Million CNY | -1.87% |
2013 | 121.03 Million CNY | 4.54% |
2012 | 132.45 Million CNY | 6.02% |
2011 | 127.04 Million CNY | 8.53% |
2010 | 99.54 Million CNY | 3.53% |
2009 | 109.43 Million CNY | -1.62% |
2008 | 109.73 Million CNY | 21.83% |
2007 | 92.14 Million CNY | 69.1% |
2006 | 43.42 Million CNY | -6.37% |
2005 | 36.14 Million CNY | 28.27% |
2004 | 37.67 Million CNY | 17.66% |
2003 | 39.48 Million CNY | 13.36% |
2002 | 34.64 Million CNY | -3.93% |
2001 | 36.25 Million CNY | -0.3% |
2000 | 31.52 Million CNY | 38.24% |
1999 | 26.3 Million CNY | -13.82% |
1998 | 25.76 Million CNY | 41.17% |
1997 | 21.62 Million CNY | -8.89% |
1996 | 23.73 Million CNY | -3.19% |
1995 | 24.51 Million CNY | -84.22% |
1994 | 155.32 Million CNY | 370.2% |
1993 | 33.03 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | -20.91 Million CNY | -136.45% |
2024 Q2 | 48.37 Million CNY | 11195.5% |
2024 Q1 | -26.9 Million CNY | 100.12% |
2023 Q1 | -23.37 Million CNY | 96.36% |
2023 Q2 | -44.97 Million CNY | -92.44% |
2023 Q3 | -46.13 Million CNY | -2.58% |
2023 Q4 | -128.91 Million CNY | -179.42% |
2023 FY | - CNY | 75.43% |
2022 Q1 | -29.16 Million CNY | -172.65% |
2022 Q2 | -72.72 Million CNY | -149.35% |
2022 FY | - CNY | -962.57% |
2022 Q4 | -642.25 Million CNY | -37672.96% |
2022 Q3 | -1.7 Million CNY | 97.66% |
2021 FY | - CNY | 202.47% |
2021 Q1 | -18.61 Million CNY | 82.55% |
2021 Q2 | -12.72 Million CNY | 31.68% |
2021 Q3 | -26.26 Million CNY | -106.44% |
2021 Q4 | -10.69 Million CNY | 59.26% |
2020 Q4 | -106.72 Million CNY | -238.21% |
2020 Q2 | 9.78 Million CNY | 117.23% |
2020 Q3 | -31.55 Million CNY | -422.47% |
2020 Q1 | -56.78 Million CNY | -114.99% |
2020 FY | - CNY | -107.2% |
2019 Q4 | 378.83 Million CNY | 98.5% |
2019 Q3 | 190.85 Million CNY | 50.35% |
2019 FY | - CNY | -33.26% |
2019 Q2 | 126.94 Million CNY | 1462.74% |
2019 Q1 | -9.31 Million CNY | -102.34% |
2018 FY | - CNY | 274.49% |
2018 Q1 | 78.38 Million CNY | -47.0% |
2018 Q2 | 795.57 Million CNY | 914.9% |
2018 Q3 | -6.91 Million CNY | -100.87% |
2018 Q4 | 397.37 Million CNY | 5845.53% |
2017 Q1 | 11.66 Million CNY | -95.76% |
2017 Q2 | 84.94 Million CNY | 628.06% |
2017 Q3 | 51.85 Million CNY | -38.95% |
2017 Q4 | 147.91 Million CNY | 185.22% |
2017 FY | - CNY | -43.15% |
2016 Q1 | 32.47 Million CNY | -74.4% |
2016 Q2 | 70.5 Million CNY | 117.11% |
2016 Q3 | 136.88 Million CNY | 94.15% |
2016 FY | - CNY | 16.92% |
2016 Q4 | 275.25 Million CNY | 101.08% |
2015 Q4 | 126.86 Million CNY | 5.38% |
2015 Q3 | 120.39 Million CNY | -1.35% |
2015 Q2 | 122.04 Million CNY | 192.19% |
2015 FY | - CNY | 316.09% |
2015 Q1 | 41.76 Million CNY | 995.91% |
2014 FY | - CNY | -1.87% |
2014 Q3 | 42.56 Million CNY | 269.64% |
2014 Q2 | 11.51 Million CNY | -74.47% |
2014 Q1 | 45.11 Million CNY | 901.37% |
2014 Q4 | -4.66 Million CNY | -110.95% |
2013 Q1 | 45.66 Million CNY | 229.26% |
2013 FY | - CNY | 4.54% |
2013 Q4 | 4.5 Million CNY | -84.11% |
2013 Q3 | 28.35 Million CNY | 41.72% |
2013 Q2 | 20 Million CNY | -56.18% |
2012 FY | - CNY | 6.02% |
2012 Q4 | 13.86 Million CNY | -41.17% |
2012 Q3 | 23.57 Million CNY | -12.72% |
2012 Q1 | 41.38 Million CNY | 136.66% |
2012 Q2 | 27 Million CNY | -34.75% |
2011 Q1 | 33.7 Million CNY | 172.97% |
2011 FY | - CNY | 8.53% |
2011 Q4 | 17.48 Million CNY | -5.43% |
2011 Q3 | 18.49 Million CNY | -27.9% |
2011 Q2 | 25.64 Million CNY | -23.91% |
2010 FY | - CNY | 3.53% |
2010 Q1 | 33.82 Million CNY | 95.41% |
2010 Q2 | 21.56 Million CNY | -36.23% |
2010 Q4 | 12.34 Million CNY | -29.24% |
2010 Q3 | 17.45 Million CNY | -19.09% |
2009 Q4 | 17.3 Million CNY | -20.4% |
2009 Q3 | 21.74 Million CNY | 43.26% |
2009 Q2 | 15.17 Million CNY | -49.83% |
2009 Q1 | 30.25 Million CNY | 65.81% |
2009 FY | - CNY | -1.62% |
2008 Q1 | 31.39 Million CNY | 76.6% |
2008 FY | - CNY | 21.83% |
2008 Q2 | 17.65 Million CNY | -43.76% |
2008 Q3 | 18.42 Million CNY | 4.4% |
2008 Q4 | 18.24 Million CNY | -0.98% |
2007 Q4 | 17.77 Million CNY | 32.97% |
2007 FY | - CNY | 69.1% |
2007 Q1 | 22.43 Million CNY | 29.07% |
2007 Q2 | 13.1 Million CNY | -41.58% |
2007 Q3 | 13.36 Million CNY | 2.0% |
2006 Q2 | 15.07 Million CNY | -20.94% |
2006 Q4 | 17.38 Million CNY | 44.34% |
2006 Q3 | 12.04 Million CNY | -20.1% |
2006 Q1 | 19.06 Million CNY | 25.99% |
2006 FY | - CNY | -6.37% |
2005 Q1 | 17.91 Million CNY | 14.34% |
2005 Q4 | 15.13 Million CNY | 26.09% |
2005 FY | - CNY | 28.27% |
2005 Q3 | 12 Million CNY | -17.88% |
2005 Q2 | 14.61 Million CNY | -18.4% |
2004 Q2 | 14.08 Million CNY | 9.02% |
2004 Q3 | 3.05 Million CNY | -78.34% |
2004 Q4 | 15.66 Million CNY | 413.33% |
2004 FY | - CNY | 17.66% |
2004 Q1 | 12.92 Million CNY | 8.95% |
2003 FY | - CNY | 13.36% |
2003 Q2 | 11.96 Million CNY | 6.74% |
2003 Q3 | 8.42 Million CNY | -29.59% |
2003 Q4 | 11.86 Million CNY | 40.83% |
2003 Q1 | 11.2 Million CNY | 38.88% |
2002 Q2 | 9.66 Million CNY | 56.83% |
2002 FY | - CNY | -3.93% |
2002 Q4 | 8.06 Million CNY | 150.07% |
2002 Q3 | 3.22 Million CNY | -66.62% |
2002 Q1 | 6.16 Million CNY | 0.0% |
2001 FY | - CNY | -0.3% |
2000 FY | - CNY | 38.24% |
1999 FY | - CNY | -13.82% |
1998 FY | - CNY | 41.17% |
1997 FY | - CNY | -8.89% |
1996 FY | - CNY | -3.19% |
1995 FY | - CNY | -84.22% |
1994 FY | - CNY | 370.2% |
1993 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Jiangsu Hengrui Medicine Co., Ltd. | 5.54 Billion CNY | 109.201% |
Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.57 Billion CNY | 114.257% |
Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.12 Billion CNY | 145.174% |
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 192.74 Million CNY | 364.474% |
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -14.11 Million CNY | -3512.352% |
NanJing Pharmaceutical Company Limited | 1.61 Billion CNY | 131.48% |
GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 157.93 Million CNY | 422.759% |
Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.55 Billion CNY | 132.741% |